லக்சை வாழ்க்கை அறிவியல் பிரைவேட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CSIR, Laxai Life Sciences to undertake trials on COVID-19 patients with Colchicine

CSIR, Laxai Life Sciences to undertake trials on COVID-19 patients with Colchicine
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Jammu and kashmirAndhra pradeshRam vishwakarmaLaxai life sciences pvtCsir indian institute of integrative medicineCouncil of scientific industrial researchCsir indian institute of chemical technologyIndustrial researchLaxai life sciencesIndian instituteChemical technologyIntegrative medicineஜம்மு மற்றும் காஷ்மீர்ஆந்திரா பிரதேஷ்ரேம் விஸ்வகர்மாலக்சை வாழ்க்கை அறிவியல் பிரைவேட்

CSIR in partnership with Laxai Life Sciences has received regulatory approval to undertake clinical trials on Covid-19 patients with Colchicine

New Delhi: Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt. Ltd. Hyderabad, have been given the regulatory approval by DCGI to undertake a two-arm phase-II clinical trial to assess the safety and efficacy of the dr

Jammu and kashmirAndhra pradeshNew delhiRam upadhayayRam vishwakarmaShekharc mandeLaxai life sciences pvtCsir indian institute of integrative medicineCouncil of scientific industrial researchCsir indian institute of chemical technologyIndustrial researchLaxai life sciencesIndian instituteChemical technologyIntegrative medicineDirector general

CSIR-Laxai Life Sciences get DCGI nod for clinical trials Colchicine on Covid patients

It is an important therapeutic intervention for Covid-19 patients with cardiac co-morbidities and also for reducing proinflammatory cytokines

Jammu and kashmirAndhra pradeshRam vishwakarmaRam upadhayayLaxai life sciences pvtCsir indian institute of integrative medicineCouncil of scientific industrial researchCsir indian institute of chemical technologyIndustrial researchLaxai life sciencesDrug controller generalIndian instituteChemical technologyIntegrative medicineClinical trialsCovid 19

CSIR begins clinical trials for Niclosamide drug as Covid-19 treatment

New Delhi [India], June 6 (ANI): Council of Scientific and Industrial Research (CSIR) along and Laxai Life Sciences Pvt. Ltd. on Sunday initiated Phase-II clinical trial for anti-helminitic drug Niclosamide for treatment of Covid-19.

Andhra pradeshNew delhiSrivari chandrashekharRam upadhayayaShekharc mandeLaxai life sciences pvtCouncil of scientificLaxai life sciencesIndustrial researchDirector generalActive pharmaceutical ingredientR shekharc mandeR ram upadhayayaPhase ii clinical trialஆந்திரா பிரதேஷ்புதியது டெல்ஹி

City firm partners with CSIR for clinical trial of Niclosamide

‘Niclosamide is generic, affordable and easily available’

Jammu and kashmirAndhra pradeshCity ofUnited kingdomRam vishwakarmaShekharc mandeRam upadhayayaNational centre for biological sciencesLaxai life sciences pvtLaxai life sciencesCouncil of scientific industrial researchCsir indian institute of integrative medicineCsir indian institute of chemical technologyKing collegeIndustrial researchGeneral shekhar